T2	Participants 109 153	patients with non-valvar atrial fibrillation
T1	Participants 489 570	patients taking part in the SPAF (stroke prevention in atrial fibrillation) study
T3	Participants 682 699	1321 participants
T4	Participants 823 866	1321 patients with atrial fibrillation (AF)
T5	Participants 1115 1139	patients with AF and CHF
T6	Participants 1970 2022	Patients with acute or recent decompensated features
